Accès gratuit
Numéro
Med Sci (Paris)
Volume 23, Numéro 5, Mai 2007
Page(s) 526 - 532
Section M/S revues
DOI https://doi.org/10.1051/medsci/2007235526
Publié en ligne 15 mai 2007
  1. Winkelsteinw JA, Marino MC, Johnston RB, et al. Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine (Baltimore) 2000; 79 : 155–69.
  2. Guichard C, Pedruzzi E, Fay M, et al. The Nox/Duox family of ROS-generating NADPHoxidases. Med Sci (Paris) 2006; 22 : 953–9.
  3. Berthier S, Paclet MH, Lerouge S, et al. Changing the conformation state of cytochrome b558 initiates NADPH oxidase activation: MRP8/MRP14 regulation. J Biol Chem 2003; 278 : 25499–508.
  4. Reeves EP, Lortat Jacobs HL, Messina CGM, et al. Killing activity of neutrophils is mediated through activation of proteases by K+ flux. Nature 2002; 416 : 291–7.
  5. Wallach TM, Segal AW. Analysis of glycosylation sites on gp91phox, the flavocytochrome of the NADPH oxidase, by site-directed mutagenesis and translation in vitro. Biochem J 1997; 321 : 583–5.
  6. Segal AW, West I, Wientjes F, et al. Cytochrome b245 is a flavocytochrome containing FAD and NADPH-binding site of the microbicidal oxidase of phagocytes Biochem J 1992; 284 : 781–8.
  7. Henderson LM, Thomas S, Banting G, Chappell JB. The arachidonate-activatable, NADPH oxidase-associated H+ channel is contained within the multi-membrane-spanning N-terminal region of gp91-phox. Biochem J 1997; 325 : 701–5.
  8. DeCoursey TE, Cherny VV, Morgan D, Katz BZ, Dinauer MC. The gp91phox component of NADPH oxidase is not the voltage-gated proton channel in phagocytes, but it helps. J Biol Chem 2001; 276 : 36063–6.
  9. Segal BH, Leto TL, Gallin JI, Malech HL, Holland SM. Genetic, biochemical, and clinical features of chronic granulomatous disease. Medicine (Baltimore) 2000; 79 : 170–200.
  10. Roos D, De Boer M, Kuribayashi F, et al. Mutations in the X-linked and autosomal recessive forms of chronic granulomatous disease. Blood 1996; 87 : 1663–81.
  11. Stasia MJ, Bordigoni P, Floret D, et al. Characterization of six novel mutations in the CYBB gene leading to different sub-types of X-linked chronic granulomatous disease. Hum Genet 2005; 116 : 72–82.
  12. Stasia MJ, Brion JP, Boutonnat J, Morel F. Severe clinical forms of cytochrome b-negative chronic granulomatous disease (X91-) in 3 brothers with a point mutation in the promoter region of CYBB. J Infect Dis 2003; 188 : 1593–604.
  13. Heyworth PG, Curnutte JT, Rae J, et al. Hematologically important mutations: X-linked chronic granulomatous disease (second update). Blood Cells Mol Dis 2001; 27 : 16–26.
  14. Heyworth PG, Cross AR, Curnutte JT. Chronic granulomatous disease. Curr Opin Immunol 2003; 15 : 578–84.
  15. Cross AR, Heyworth PG, Rae J, Curnutte JT. A variant X-linked chronic granulomatous disease patient (X91+) with partially functional cytochrome b. J Biol Chem 1995; 270 : 8194–8200.
  16. Stasia MJ, Lardy B, Maturana A, et al. Molecular and functional characterization of a new X-linked chronic granulomatous disease variant (X91+) case with a double missense mutation in the gp91-phox-cytosolique C-terminal tail. Biochem Biophys Acta 2002; 1586 : 316–30.
  17. Leusen JH, de Boer M, Bolscher BG, et al. A point mutation in gp91-phox of cytochrome b558 of the human NADPH oxidase leading to defective translocation of the cytosolic proteins p47-phox and p67-phox. J Clin Invest 1994; 93 : 2120–6.
  18. Leusen JH, Meischl C, Eppink MH, et al. Four novel mutations in the gene encoding gp91-phox of human NADPH oxidase : consequences for oxidase assembly. Blood 2000; 95 : 666–73.
  19. Dinauer MC, Curnutte JT, Rosen H, Orkin SH. A missense mutation in the neutrophil cytochrome b heavy chain in cytochrome-positive X-linked chronic granulomatous disease. J Clin Invest 1989; 84 : 2012–6.
  20. Tucker KA, Lilly MB, Heck L, Rado TA. Characterization of a new human diploid myeloid leukaemia cell line (PLB-985). Blood 1987; 70 : 372–8.
  21. Zhen L, King AA, Xiao Y, et al. Gene targeting of X chromosome-linked chronic granulomatous disease locus in a human myeloid leukemia cell line and rescue by expression of recombinant gp91phox. Proc Natl Acad Sci USA 1993; 90 : 9832–6.
  22. Schapiro BL, Newburger PE, Klempner MS, Dinauer MC. Chronic granulomatous disease presenting in a 69-year-old man. N Engl J Med 1991; 325 : 1786–90.
  23. Yu L, Cross AR, Zhen L, Dinauer MC. Functional analysis of NADPH oxidase in granulocytic cells expressing a delta488-497 gp91(phox) deletion mutant. Blood 1999; 94 : 2497–504.
  24. Lambeth JD. NOX enzymes and the biology of reactive oxygen. Nat Rev Immunol 2004; 4 : 181–9.
  25. Taylor WR, Jones DT, Segal AW. A structural model for the nucleotide binding domains of the flavocytochrome b-245 beta-chain. Protein Sci 1993; 2 : 1675–85.
  26. Li, XJ, Grunwald D, Mathieu J, Morel F, Stasia MJ. Crucial role of two potential cytosolic regions of Nox2, 191TSSTKTIRRS200 and 484DESQANHFAVHHDEEKD500, on NADPH oxidase activation. J Biol Chem 2005; 280 : 14962–73.
  27. Li XJ, Fieschi F, Paclet MH, et al. Leu505 of Nox2 is crucial for optimal p67phox-dependent activation of the flavocytochrome b558 during phagocytic NADPH oxidase assembly. J Leukoc Biol 2007; 81 : 238–49.
  28. Shatwell KP, Dancis A, Cross AR, Klausner RD, Segal AW. The FRE1 ferric reductase of Saccharomyces cerevisiae is a cytochrome b similar to that of NADPH oxidase. J Biol Chem 1996; 271 : 14240–4.
  29. Karplus PA, Daniels MJ, Herriott JR. Atomic structure of ferredoxin-NADP+ reductase : prototype for a structurally novel flavoenzyme family. Science 1991; 251 : 60–6.
  30. Bionda C, Li XJ, van Bruggen R, et al. Functional analysis of a two-amino acid substitution in gp91phox in a patient with X-linked flavocytochrome-b558-positive chronic granulomatous disease by means of transgenic PLB-985 cells. Hum Genet 2004; 115 : 418–27.

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.